- Home
- PRQR vs SY Comparison
PRQR vs SY Comparison
Compare PRQR & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | SY |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Netherlands | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 289.0M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PRQR | SY |
|---|---|---|
| Price | $2.34 | $2.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $8.14 | $5.50 |
| AVG Volume (30 Days) | 348.1K | ★ 1.9M |
| Earning Date | 11-06-2025 | 11-17-2025 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,859,556.00 | ★ $201,132,009.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | N/A | $54.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.07 | $0.67 |
| 52 Week High | $3.97 | $6.28 |
Technical Indicators
Market Signals| Indicator | PRQR | SY |
|---|---|---|
| Relative Strength Index (RSI) | 53.26 | 40.90 |
| Support Level | $2.10 | $2.83 |
| Resistance Level | $2.40 | $3.20 |
| Average True Range (ATR) | 0.17 | 0.36 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 89.49 | 6.22 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.